Effective with date of service May 15, 2023, NC Medicaid covers pegfilgrastim-pbbk injection, for subcutaneous use (Fylnetra).
Medicaid Bulletin
Articles published prior to January 2018 are available in the Medicaid Bulletin Archive.
Effective with date of service April 21, 2023, NC Medicaid covers paclitaxel protein-bound particles for injectable suspension, (albumin-bound)
Updates include updated policies on Acuity Tiers, Acuity-Based Contacts and Contact Monitoring.
Effective with date of service April 17, 2023, NC Medicaid covers bevacizumab-adcd injection, for intravenous use (Vegzelma)
Effective May 30, 2023, NC Medicaid covers aripiprazole extended-release injectable suspension, for intramuscular use (Abilify Asimtufii).
This bulletin provides details on coverage for COVID-19 Vaccines and COVID-19 Counseling after the ending of the Federal Public Health Emergency.
Effective July 1, 2023, NC Medicaid has increased the Medicaid rate for Maternal Bundled Payments for pregnancy care.
A draft application for § 1915 (c) NC Innovation Waiver is posted for a 30-day public comment period.
The North Carolina Department of Health and Human Services recently awarded Acentra Health the contract as the Comprehensive Independent Assessment Entity (CIAE) for NC Medicaid.
Beneficiaries who will be covered by the Tailored Plans will continue to receive care as they do today.